Steven A. Kriegsman, Director at RXI PHARMACEUTICALS CORP (RXII), sold 5,000 shares at $5.11 ($25K) on 2009-06-03, disclosed to the SEC on 2009-06-05.
Scheduled sale ($25k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.11 | 2,400 | $12K | 48.8% |
| 2 | $4.94 | 2,600 | $13K | 51.2% |
| Total | $5.02 avg | 5,000 | $25K | 100% |
| Filing → |
| CYTR | BUY | 2012-02-24 | $51K | — | Filing → |
| RXII | SELL | 2009-08-20 | $28K | — | Filing → |
| RXII | SELL | 2009-07-06 | $13K | — | Filing → |